|
|
||||||||
From the Department of Ophthalmology, University of Texas, Southwestern Medical Center, Dallas, Texas.
PURPOSE. To determine whether the Th1 cytokine, interferon (IFN)-
, is necessary for corneal graft rejection.
METHODS. Full-thickness penetrating keratoplasties were performed in normal mice and in IFN-
knockout (KO) mice.
RESULTS. Sixty-four percent of the MHC-mismatched corneal allografts were rejected in IFN-
KO mice. By contrast, MHC-matched corneal allografts were rejected in 50% to 77% of the wild-type hosts, but were not rejected in any of the IFN-
KO mice or the wild-type mice treated with anti-IFN-
monoclonal antibody. Corneal graft rejection in IFN-
deficient hosts was characterized by an eosinophilic infiltrate compared with a mononuclear inflammatory infiltrate in normal mice.
CONCLUSIONS. IFN-
is not necessary for the rejection of MHC-mismatched corneal grafts. However, IFN-
and Th1 immune mechanisms are necessary for the rejection of MHC-matched corneal allografts that confront the host with foreign minor histocompatibility antigens. The immune response in atopic patients, as in IFN-
KO mice, is characterized by cross-regulation of Th1 cytokines, such as IFN-
. The present results indicate that MHC matching dramatically reduces the risk of corneal graft rejection when IFN-
is depressed or absent. Thus, MHC matching may reduce the risk of corneal graft rejection in patients with atopic keratoconus.
This article has been cited by other articles:
![]() |
T. Hayashi, S. Yamagami, K. Tanaka, S. Yokoo, T. Usui, S. Amano, and N. Mizuki Immunologic Mechanisms of Corneal Allografts Reconstituted from Cultured Allogeneic Endothelial Cells in an Immune-Privileged Site Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3151 - 3158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yamada, J. Hamuro, A. Fukushima, T. Ohteki, K. Terai, Y. Iwakura, H. Yagita, and S. Kinoshita MHC-Matched Corneal Allograft Rejection in an IFN-{gamma}/IL-17-Independent Manner in C57BL/6 Mice Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2139 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beauregard, C. Stevens, E. Mayhew, and J. Y. Niederkorn Cutting Edge: Atopy Promotes Th2 Responses to Alloantigens and Increases the Incidence and Tempo of Corneal Allograft Rejection J. Immunol., June 1, 2005; 174(11): 6577 - 6581. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |